Researchers believe that CBDA could be the next big medication for treating and maintaining overall mental and physical well-being.
Cannabidiolic acid (CBDA) is a minor cannabinoid with significant medicinal promise. Recent research suggests that CBDA could be an alternative treatment for managing or curing inflammation, anxiety, cancer, and seizures. The therapeutic potential of CBDA is the newest discovery of cannabinoid-based drugs.
Introduction to CBDA
Although research is still in the infant stage, researchers believe that CBDA could be the next big medication for treating and maintaining overall mental and physical well-being. Many cannabis-based scientists are optimistic that CBDA would reduce the need for conventional drugs with long-term side effects.
CBDA is mainly found in cannabis plant material. Like other major and minor cannabinoids, it reacts with the body’s endocannabinoid system and receptors in the central nervous system and immune system.
Conversion of CBGA to CBDA
CBGA is converted into CBDA by an enzymatic process. Once formed, it remains this way until the decarboxylation process takes place. Decarboxylation is the conversion of acidic cannabinoids to their decarboxylated forms. CBDA is converted to CBD, THCA to THC, and CBCA to CBC. When cannabis is heated, the decarboxylation process takes place. Cannabinoids’ molecular structure changes when they are heated, dried, or treated. The method alters the substance’s chemical structure by removing one acidic carboxyl group.
While certain cannabis plants have been cultivated to contain balanced quantities of CBDA and THCA, CBDA is often only found in very small concentrations in cannabis plants. Mainly hemp plants are well-known for having significant levels of CBDA and traces of THCA.